Literature DB >> 28349994

Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Carol Durno1, C Richard Boland2, Shlomi Cohen3, Jason A Dominitz4,5, Frank M Giardiello6, David A Johnson7, Tonya Kaltenbach8, T R Levin9, David Lieberman10, Douglas J Robertson11,12, Douglas K Rex13.   

Abstract

The US Multi-Society Task Force on Colorectal Cancer, with invited experts, developed a consensus statement and recommendations to assist health care providers with appropriate management of patients with biallelic mismatch repair deficiency (BMMRD) syndrome, also called constitutional mismatch repair deficiency syndrome. This position paper outlines what is known about BMMRD, the unique genetic and clinical aspects of the disease, and reviews the current management approaches to this disorder. This article represents a starting point from which diagnostic and management decisions can undergo rigorous testing for efficacy. There is a lack of strong evidence and a requirement for further research. Nevertheless, providers need direction on how to recognize and care for BMMRD patients today. In addition to identifying areas of research, this article provides guidance for surveillance and management. The major challenge is that BMMRD is rare, limiting the ability to accumulate unbiased data and develop controlled prospective trials. The formation of effective international consortia that collaborate and share data is proposed to accelerate our understanding of this disease.

Entities:  

Mesh:

Year:  2017        PMID: 28349994     DOI: 10.1038/ajg.2017.105

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  1 in total

Review 1.  Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels.

Authors:  Salman Nusrat; Taseen Syed; Sanober Nusrat; Sixia Chen; Wei-Jen Chen; Klaus Bielefeldt
Journal:  JAMA Netw Open       Date:  2018-12-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.